Radiogenomics models in precision radiotherapy: from mechanistic to machine learning
暂无分享,去创建一个
[1] J. Hendry,et al. Radiobiology for the Radiologist , 1979, British Journal of Cancer.
[2] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[3] H D Thames,et al. Evidence for individual differences in the radiosensitivity of human skin. , 1992, European journal of cancer.
[4] Lawrence D. Jackel,et al. Learning Curves: Asymptotic Values and Rate of Convergence , 1993, NIPS.
[5] J. Overgaard,et al. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. , 1993, European journal of cancer.
[6] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[7] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[8] Ron Kohavi,et al. Wrappers for Feature Subset Selection , 1997, Artif. Intell..
[9] G.E. Moore,et al. Cramming More Components Onto Integrated Circuits , 1998, Proceedings of the IEEE.
[10] M. Opper,et al. Statistical mechanics of Support Vector networks. , 1998, cond-mat/9811421.
[11] Arthur E. Hoerl,et al. Ridge Regression: Biased Estimation for Nonorthogonal Problems , 2000, Technometrics.
[12] Jonathan A C Sterne,et al. Sifting the evidence—what's wrong with significance tests? , 2001, BMJ : British Medical Journal.
[13] Leo Breiman,et al. Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001 .
[14] H. Cordell. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.
[15] C. Begg,et al. Two‐Stage Designs for Gene–Disease Association Studies , 2002, Biometrics.
[16] J. Hendry,et al. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[17] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[18] Sayan Mukherjee,et al. Estimating Dataset Size Requirements for Classifying DNA Microarray Data , 2003, J. Comput. Biol..
[19] Isabelle Guyon,et al. An Introduction to Variable and Feature Selection , 2003, J. Mach. Learn. Res..
[20] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[21] K. Lunetta,et al. Screening large-scale association study data: exploiting interactions using random forests , 2004, BMC Genetics.
[22] Larry Wasserman,et al. All of Statistics: A Concise Course in Statistical Inference , 2004 .
[23] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[24] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[25] Joos V Lebesque,et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. , 2006, International journal of radiation oncology, biology, physics.
[26] D. Reich,et al. Population Structure and Eigenanalysis , 2006, PLoS genetics.
[27] William Stafford Noble,et al. Support vector machine , 2013 .
[28] I El Naqa,et al. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose–volume outcome relationships , 2006, Physics in medicine and biology.
[29] Jianqing Fan,et al. Sure independence screening for ultrahigh dimensional feature space , 2006, math/0612857.
[30] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[31] J. Deasy,et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. , 2006, International journal of radiation oncology, biology, physics.
[32] Christopher M. Bishop,et al. Pattern Recognition and Machine Learning (Information Science and Statistics) , 2006 .
[33] N G Burnet,et al. Radiosensitivity, radiogenomics and RAPPER. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).
[34] G. Moore. Cramming more components onto integrated circuits, Reprinted from Electronics, volume 38, number 8, April 19, 1965, pp.114 ff. , 2006, IEEE Solid-State Circuits Newsletter.
[35] G. Abecasis,et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.
[36] R. Tibshirani,et al. "Preconditioning" for feature selection and regression in high-dimensional problems , 2007, math/0703858.
[37] G. Abecasis,et al. Optimal designs for two‐stage genome‐wide association studies , 2007, Genetic epidemiology.
[38] Geoffrey E. Hinton,et al. Visualizing Data using t-SNE , 2008 .
[39] G. Clark,et al. Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib , 2008, Molecular oncology.
[40] Sun I. Kim,et al. Nonlinear Support Vector Machine Visualization for Risk Factor Analysis Using Nomograms and Localized Radial Basis Function Kernels , 2008, IEEE Transactions on Information Technology in Biomedicine.
[41] Radhe Mohan,et al. Analysis of radiation pneumonitis risk using a generalized Lyman model. , 2008, International journal of radiation oncology, biology, physics.
[42] N. Meinshausen,et al. Stability selection , 2008, 0809.2932.
[43] Yichao Wu,et al. Ultrahigh Dimensional Feature Selection: Beyond The Linear Model , 2009, J. Mach. Learn. Res..
[44] L. Wasserman,et al. HIGH DIMENSIONAL VARIABLE SELECTION. , 2007, Annals of statistics.
[45] Jason H. Moore,et al. Spatially Uniform ReliefF (SURF) for computationally-efficient filtering of gene-gene interactions , 2009, BioData Mining.
[46] J. Alsner,et al. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] Trevor J. Hastie,et al. Genome-wide association analysis by lasso penalized logistic regression , 2009, Bioinform..
[48] Ananya Choudhury,et al. MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. , 2010, Cancer research.
[49] Joseph O Deasy,et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. , 2010, International journal of radiation oncology, biology, physics.
[50] Stephen J O'Brien,et al. Accounting for multiple comparisons in a genome-wide association study (GWAS) , 2010, BMC Genomics.
[51] K. Roeder,et al. Screen and clean: a tool for identifying interactions in genome‐wide association studies , 2010, Genetic epidemiology.
[52] Patrick F. Sullivan,et al. A quality control algorithm for filtering SNPs in genome-wide association studies , 2010, Bioinform..
[53] Barry S Rosenstein,et al. Establishment of a radiogenomics consortium. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] Asako Koike,et al. SNPInterForest: A new method for detecting epistatic interactions , 2011, BMC Bioinformatics.
[55] E. Boerwinkle,et al. Mining gold dust under the genome wide significance level: a two‐stage approach to analysis of GWAS , 2011, Genetic epidemiology.
[56] Satish Chikkagoudar,et al. Ranking causal variants and associated regions in genome-wide association studies by the support vector machine and random forest , 2011, Nucleic acids research.
[57] Jean Yee Hwa Yang,et al. Gene-gene interaction filtering with ensemble of filters , 2011, BMC Bioinformatics.
[58] Rongling Li,et al. Quality Control Procedures for Genome‐Wide Association Studies , 2011, Current protocols in human genetics.
[59] Xin Wang,et al. SNP interaction detection with Random Forests in high-dimensional genetic data , 2012, BMC Bioinformatics.
[60] Annette M. Molinaro,et al. Power of Data Mining Methods to Detect Genetic Associations and Interactions , 2011, Human Heredity.
[61] Joseph O Deasy,et al. A Bayesian network approach for modeling local failure in lung cancer , 2011, Physics in medicine and biology.
[62] Suzanne L Wolden,et al. Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. , 2011, International journal of radiation oncology, biology, physics.
[63] Q. Wei,et al. Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[64] A. Italiano,et al. Prognostic or predictive? It's time to get back to definitions! , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] Yudi Pawitan,et al. Validation of a Radiosensitivity Molecular Signature in Breast Cancer , 2012, Clinical Cancer Research.
[66] Arndt Hartmann,et al. Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer , 2012, BJU international.
[67] J. Torres-Roca,et al. A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy. , 2012, Personalized medicine.
[68] M. Sydes,et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. , 2012, The Lancet. Oncology.
[69] Daniel Gomez,et al. Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[70] Joos V Lebesque,et al. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer. , 2012, International journal of radiation oncology, biology, physics.
[71] Andrea Ottolenghi,et al. Biological mechanisms of normal tissue damage: importance for the design of NTCP models. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[72] X. Chen,et al. Random forests for genomic data analysis. , 2012, Genomics.
[73] J Chang-Claude,et al. A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy , 2012, British Journal of Cancer.
[74] J. Ogutu,et al. Genomic selection using regularized linear regression models: ridge regression, lasso, elastic net and their extensions , 2012, BMC Proceedings.
[75] Petra Seibold,et al. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[76] Radhe Mohan,et al. Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer. , 2013, International journal of radiation oncology, biology, physics.
[77] Radhe Mohan,et al. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. , 2013, International journal of radiation oncology, biology, physics.
[78] Jim Davies,et al. Data-driven Markov models and their application in the evaluation of adverse events in radiotherapy , 2013, Journal of radiation research.
[79] J. Beck,et al. Cancer Patients’ Trade-offs Among Efficacy, Toxicity, and Out-of-Pocket Cost in the Curative and Noncurative Setting , 2013, Medical care.
[80] C. Belka,et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients , 2013, Radiation Oncology.
[81] James J. Gallagher,et al. Reply to , 2014 .
[82] Alison M Dunning,et al. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 , 2014, Nature Genetics.
[83] S. Eschrich,et al. A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancer , 2014, medRxiv.
[84] T. Salakoski,et al. Regularized Machine Learning in the Genetic Prediction of Complex Traits , 2014, PLoS genetics.
[85] Chris S. Haley,et al. Detecting epistasis in human complex traits , 2014, Nature Reviews Genetics.
[86] S. Eschrich,et al. A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer , 2014 .
[87] T. Ørntoft,et al. Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[88] J. Chang-Claude,et al. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. , 2015, International journal of radiation oncology, biology, physics.
[89] P. Zandi,et al. Whole-genome CNV analysis: advances in computational approaches , 2015, Front. Genet..
[90] Jeffrey D Bradley,et al. Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk. , 2015, Medical physics.
[91] Issam El Naqa,et al. Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[92] Martin J. Murphy,et al. Machine Learning in Radiation Oncology , 2015 .
[93] Jason H Moore,et al. Epistasis analysis using ReliefF. , 2015, Methods in molecular biology.
[94] J. R. MacDonald,et al. A copy number variation map of the human genome , 2015, Nature Reviews Genetics.
[95] K. Ballman,et al. Biomarker: Predictive or Prognostic? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] Mufaddal Mamawala,et al. Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[97] J. Flickinger,et al. Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective. , 2015, International journal of radiation oncology, biology, physics.
[98] James Coates,et al. Motivation for the inclusion of genetic risk factors of radiosensitivity alongside dosimetric and clinical parameters in predicting normal tissue effects , 2015, Acta oncologica.
[99] William Stafford Noble,et al. Machine learning applications in genetics and genomics , 2015, Nature Reviews Genetics.
[100] Venkat Reddy Konasani,et al. Multiple Regression Analysis , 2015 .
[101] B. Vogelstein,et al. PD-1 blockade in tumors with mismatch repair deficiency. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] Gaetano Rocco,et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] Virginia G Kaklamani,et al. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. , 2015, The New England journal of medicine.
[104] Felix Y. Feng,et al. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer , 2015, Clinical Cancer Research.
[105] A. Nahum,et al. The performance of normal-tissue complication probability models in the presence of confounding factors. , 2015, Medical physics.
[106] Johannes Gehrke,et al. Intelligible Models for HealthCare: Predicting Pneumonia Risk and Hospital 30-day Readmission , 2015, KDD.
[107] R. Stupp,et al. Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma? , 2015, Neuro-oncology.
[108] Honghao Zhou,et al. Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment. , 2015, Carcinogenesis.
[109] Qingyao Wu,et al. Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests , 2015, BMC Genomics.
[110] E. Basch,et al. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments , 2016, Nature Reviews Clinical Oncology.
[111] Martin Wattenberg,et al. How to Use t-SNE Effectively , 2016 .
[112] Petra Seibold,et al. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[113] Adam P Dicker,et al. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. , 2016, The Lancet. Oncology.
[114] P. Tamayo,et al. A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.
[115] William S Bush,et al. Are Interactions between cis-Regulatory Variants Evidence for Biological Epistasis or Statistical Artifacts? , 2016, American journal of human genetics.
[116] M. Atkinson,et al. MicroRNAs as novel elements in personalized radiotherapy , 2016 .
[117] L. Ungar,et al. MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine , 2016, Scientific Reports.
[118] Gilles Blanchard,et al. Combining Multiple Hypothesis Testing with Machine Learning Increases the Statistical Power of Genome-wide Association Studies , 2016, Scientific Reports.
[119] Christian Nicolaj Andreassen,et al. Radiogenomics - current status, challenges and future directions. , 2016, Cancer letters.
[120] Issam El Naqa,et al. Big Data Analytics for Prostate Radiotherapy , 2016, Front. Oncol..
[121] Mechthild Krause,et al. Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.
[122] Joseph O. Deasy,et al. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes , 2017, Scientific Reports.
[123] A. Chen,et al. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH. , 2017, Current problems in cancer.
[124] D. Shin,et al. Poster ViewingCirculating Pre-treatment miRNAs as Potential Biomarkers to Predict Radiation Toxicity , 2017 .
[125] M. Kraemer,et al. A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies , 2017, Supportive Care in Cancer.
[126] Mykel J. Kochenderfer,et al. Learning Discrete Bayesian Networks from Continuous Data , 2015, J. Artif. Intell. Res..
[127] C. Simone,et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. , 2017, Practical radiation oncology.
[128] D. Osoba,et al. Short‐Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma , 2017, The New England journal of medicine.
[129] D. Spratt,et al. Genomic-adjusted radiation dose. , 2017, The Lancet. Oncology.
[130] S. Jolly,et al. Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[131] Issam El Naqa,et al. Radiogenomics and radiotherapy response modeling , 2017, Physics in medicine and biology.
[132] Gonçalo R. Abecasis,et al. GAS Power Calculator: web-based power calculator for genetic association studies , 2017, bioRxiv.
[133] Jacob G. Scott,et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. , 2017, The Lancet. Oncology.
[134] Wentian Li,et al. Application of t-SNE to Human Genetic Data , 2017, bioRxiv.
[135] D. Matei,et al. A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. , 2017 .
[136] B. Rosenstein. Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. , 2017, Seminars in radiation oncology.
[137] W. Woodward,et al. Association of Transforming Growth Factor &bgr; Polymorphism C−509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial , 2018, JAMA oncology.
[138] A. Tafreshi,et al. Pembrolizumab plus Chemotherapy for Squamous Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.
[139] Suneetha Uppu,et al. A Review on Methods for Detecting SNP Interactions in High-Dimensional Genomic Data , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[140] Jean L Wright,et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. , 2018, Practical radiation oncology.
[141] Timothy D. Solberg,et al. Machine Learning in Radiation Oncology: Opportunities, Requirements, and Needs , 2018, Front. Oncol..
[142] S. Novello,et al. Pembrolizumab plus Chemotherapy in Metastatic Non–Small‐Cell Lung Cancer , 2018, The New England journal of medicine.
[143] R. Epstein,et al. Willingness to bear adversity and beliefs about the curability of advanced cancer. , 2018, Journal of Clinical Oncology.
[144] Jacob G. Scott,et al. Machine Learning and Radiogenomics: Lessons Learned and Future Directions , 2018, Front. Oncol..
[145] D. Spratt. Ki-67 Remains Solely a Prognostic Biomarker in Localized Prostate Cancer. , 2018, International journal of radiation oncology, biology, physics.
[146] Gilmer Valdes,et al. Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation? , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[147] S. Jolly,et al. Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. , 2018, International journal of radiation oncology, biology, physics.
[148] D Ruan,et al. Treatment data and technical process challenges for practical big data efforts in radiation oncology , 2018, Medical physics.
[149] C. N. Coleman,et al. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. , 2017, International journal of radiation oncology, biology, physics.
[150] Issam El Naqa,et al. A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall‐cell lung cancer (NSCLC) for response‐adapted radiotherapy , 2018, Medical physics.
[151] Elena Rojano,et al. Analyzing the Effects of Genetic Variation in Noncoding Genomic Regions , 2018 .
[152] K. Hoffman,et al. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. , 2018, Practical radiation oncology.
[153] K. Brock,et al. On the Fuzziness of Machine Learning, Neural Networks, and Artificial Intelligence in Radiation Oncology. , 2018, International journal of radiation oncology, biology, physics.
[154] Issam El Naqa,et al. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways. , 2018, International journal of radiation oncology, biology, physics.
[155] G. Ying,et al. Factors Associated with Occurrence of Radiation-induced Optic Neuropathy at “Safe” Radiation Dosage , 2018, Seminars in ophthalmology.
[156] T. Zhou,et al. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[157] R. Huddart,et al. MRE 11 as a predictive biomarker of outcome following radiotherapy in bladder cancer , 2019 .
[158] A Jackson,et al. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients. , 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).
[159] Martin Glas,et al. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial , 2019, The Lancet.